Genflow Biosciences (GENF) Competitors GBX 1.08 +0.14 (+14.48%) As of 12:26 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock GENF vs. RLM, NSCI, IXI, OPTI, OBD, FUM, SNG, BVX, TRX, and CIZShould you be buying Genflow Biosciences stock or one of its competitors? The main competitors of Genflow Biosciences include Realm Therapeutics (RLM), NetScientific (NSCI), IXICO (IXI), OptiBiotix Health (OPTI), Oxford BioDynamics (OBD), Futura Medical (FUM), Synairgen (SNG), BiVictriX Therapeutics (BVX), Tissue Regenix Group (TRX), and Cizzle Biotechnology (CIZ). These companies are all part of the "biotechnology" industry. Genflow Biosciences vs. Its Competitors Realm Therapeutics NetScientific IXICO OptiBiotix Health Oxford BioDynamics Futura Medical Synairgen BiVictriX Therapeutics Tissue Regenix Group Cizzle Biotechnology Realm Therapeutics (LON:RLM) and Genflow Biosciences (LON:GENF) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends. Do insiders & institutionals believe in RLM or GENF? 2.7% of Genflow Biosciences shares are owned by institutional investors. 42.8% of Genflow Biosciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better earnings and valuation, RLM or GENF? Realm Therapeutics has higher revenue and earnings than Genflow Biosciences. Genflow Biosciences is trading at a lower price-to-earnings ratio than Realm Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRealm Therapeutics£501.92K0.00N/A-£17.50N/AGenflow BiosciencesN/AN/A-£1.76M-£0.01-214.14 Does the media favor RLM or GENF? In the previous week, Genflow Biosciences had 3 more articles in the media than Realm Therapeutics. MarketBeat recorded 3 mentions for Genflow Biosciences and 0 mentions for Realm Therapeutics. Genflow Biosciences' average media sentiment score of 0.13 beat Realm Therapeutics' score of 0.00 indicating that Genflow Biosciences is being referred to more favorably in the news media. Company Overall Sentiment Realm Therapeutics Neutral Genflow Biosciences Neutral Is RLM or GENF more profitable? Genflow Biosciences has a net margin of 778.46% compared to Realm Therapeutics' net margin of 0.00%. Realm Therapeutics' return on equity of 0.00% beat Genflow Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Realm TherapeuticsN/A N/A N/A Genflow Biosciences 778.46%-208.12%-58.66% SummaryGenflow Biosciences beats Realm Therapeutics on 6 of the 10 factors compared between the two stocks. Get Genflow Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GENF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GENF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GENF vs. The Competition Export to ExcelMetricGenflow BiosciencesBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£4.88M£231.50M£6.11B£2.60BDividend YieldN/A3.80%5.66%5.29%P/E Ratio-214.1494.7185.714,449.23Price / SalesN/A6,040.75527.7899,976.50Price / Cash3.0013.1926.3027.90Price / Book4.33113.4612.888.33Net Income-£1.76M-£90.99M£3.30B£5.89B7 Day Performance-29.37%4.92%4.28%0.99%1 Month Performance26.32%7.89%7.57%6.24%1 Year Performance-47.56%643.13%75.50%158.60% Genflow Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GENFGenflow BiosciencesN/AGBX 1.08+14.5%N/A-54.2%£4.88MN/A-214.145Earnings ReportHigh Trading VolumeRLMRealm TherapeuticsN/AN/AN/AN/A£13.41M£501.92K-0.66N/ANSCINetScientificN/AN/AN/AN/A£12.81M£1.45M-486.3626IXIIXICON/AGBX 12-9.4%N/A+33.3%£11.12M£6.44M-515.0289High Trading VolumeOPTIOptiBiotix HealthN/AGBX 10.55-4.1%N/A-28.5%£10.90M£1.15M-573.481Positive NewsOBDOxford BioDynamicsN/AGBX 0.53-4.5%N/A-84.2%£10.28M£896K-18.1045Gap UpFUMFutura MedicalN/AGBX 3.30-6.3%N/A-89.9%£10.03M£13.93M804.8812Earnings ReportGap DownSNGSynairgenN/AN/AN/AN/A£9.04MN/A-0.5634Gap DownBVXBiVictriX TherapeuticsN/AN/AN/AN/A£8.25MN/A-250.0017Gap UpHigh Trading VolumeTRXTissue Regenix GroupN/AGBX 10.50flatN/A-80.6%£7.48M£28.65M-1,050.00120Gap UpHigh Trading VolumeCIZCizzle BiotechnologyN/AGBX 1.29-8.0%N/A-37.8%£5.11MN/A-214.674Earnings ReportGap Down Related Companies and Tools Related Companies RLM Competitors NSCI Competitors IXI Competitors OPTI Competitors OBD Competitors FUM Competitors SNG Competitors BVX Competitors TRX Competitors CIZ Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:GENF) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersThe next wave of AI fortunes may come from NVIDIA’s secret supplier.Bloomberg says AI is a $50 trillion revolution. And at the center of it… isn't NVIDIA. It's a tiny suppl...Behind the Markets | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dolla...The Oxford Club | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredRIP USA"The America you knew is dying in front of you" That's the urgent warning the former $200 million hedge fun...Stansberry Research | SponsoredOctober 2025 Market Crash?Wall Street Legend Names #1 Stock [not NVDA] The greatest quantitative mind on Wall Street just revealed hi...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genflow Biosciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Genflow Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
